SPI Pharma Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press
Claim your profile

Estimated Revenue & Financials

  • SPI Pharma's estimated annual revenue is currently $66.1M per year.
  • SPI Pharma's estimated revenue per employee is $201,000

Employee Data

  • SPI Pharma has 329 Employees.
  • SPI Pharma grew their employee count by 74% last year.
  • SPI Pharma currently has 8 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
SPI Pharma
$66.1M32974%N/A
Synchrogenix, a...
$60.1M299-8%N/A
ILC Dover
$80.6M40110%N/A
BioTek reMEDys
$9.4M4715%N/A
Incyte Corporat...
N/A1606N/AN/A
Noramco
N/A194N/AN/A
Ayala Pharmaceu...
$6.8M3417%N/A
Missing a competitor? Contribute!?
Submit

For over 75 years, we have supplied the pharmaceutical industry with highly engineered products and innovative solutions that improve the formulation and delivery of drug products to meet patient needs. Our functional excipients and active ingredients meet the highest-quality standards possible and can offer customized, cost-effective options for many applications. We invite you to explore our product offerings. Our global technical team of experts can also help you select the right product to solve your formulation challenge.

keywords:N/A

329

Number of Employees

$66.1M

Revenue (est)

8

Current Jobs

74%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Quentis RogersVice President of SalesEmail Available
Lynne WebbProduct ManagerEmail Available
Coralyn GonzalezHead Of Global Sales Excipients, Drug Delivery SystemsEmail Available
Paul SwarmEnvironmental, Health and Safety ManagerEmail Available
Bhagya NarayanAccount ManagerEmail Available
Ange KaminExport/ Client Relationship ManagerEmail Available
Colleen BlackneyKey Acount Manager
Katie KristoficGlobal Marketing and Communications ManagerEmail Available
Joe FassanoDirectorEmail Available
David BonillaHead of Quality, Delaware sitesEmail Available

SPI Pharma News

09/03/2019 - Future prospect of China Vaccine Adjuvants Market to Drive Tremendous Growth by 2025: Major Players-| SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma, MVP Laboratories, Tj Kaiwei, Novavax, Zhuoyue,

Companies Profiled in this Report includes, SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma, MVP Laboratories, Tj Kaiwei, Novavax, ...

09/08/2019 - Vaccine Adjuvants Market Size, Growth, Trends | Industry Report, 2019 – 2025| SDA BIO, Brenntag Biosector, SPI Pharma

Los Angeles, United State, Sept 9, 2019, – The global Vaccine Adjuvants market is exhaustively researched and analyzed in the report to help ...

09/03/2019 - Global Vaccine Adjuvants Market Analysis, Growth, Demand ...

The industrial dominant players SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma, MVP Laboratories, Tj Kaiwei, Novavax, Zhuoyue, Aphios, ...